HDFC, Tech Mahindra among 10 stocks brokerages recommend 'buy' post Q3
Benchmark indices slipped into the negative territory today following the Economic Survey for 2017-18
‘Disclaimer: This story is for informational purposes only and should not be taken as investment advice.'
Even as the benchmark indices slipped into the negative territory following the Economic Survey for 2017-18, which was tabled in Parliament yesterday, brokerages have buy call for the following stocks.
Shriram City Union Finance (SCUF IN, Rs 2,115, Buy)
Shriram City Union’s Q3FY18 PAT of Rs 2.3bn (up >40% YoY) surpassed our expectation. Key highlight was lower credit cost at 3.1% with scope for further improvement. Asset quality was steady with GNPLs (120 dpd) at 6.77% (6.9% in Q2FY18). Revenue momentum gained better than anticipated traction (NII >20% YoY) on better margin profile (up 11bps QoQ to ~14.4%). Growth momentum improved – disbursements up 23% YoY, translating into 15.7% AUM growth (still below historical run-rate). However, higher than expected opex (up 30% YoY) partially restricted core profitability. Overall performance was encouraging, especially in backdrop of concerns around GST and demonetisation. Given ~4% RoA, healthy CAR of 22% and improving growth visibility, we maintain ‘BUY’.
Tech Mahindra (TECHM IN, Rs 605, Buy)
Tech Mahindra (TECHM) reported stellar Q3FY18 with 2.5% QoQ USD revenue growth (Street estimate 1.7%) to USD1,209mn and 180bps QoQ margin expansion to 16.3% (Street’s 15.2% estimate). Key highlights: 1) robust 4.4% QoQ spurt in enterprise business; 2) margin improvement led by utilisation, business mix & profitability of portfolio companies; and 3) management signalled early signs of 5G capex are visible.
We maintain our thesis that TECHM has highest margin levers (although played out much earlier), its enterprise business is on strong footing and now with green shoots of 5G capex visible, all the ingredients for high revenue/EPS CAGR are in place. Hence, we raise our target multiple to 15x (14x earlier). Maintain ‘BUY’ with revised TP of Rs740 (Rs 546 earlier).
L&T Finance Holdings (LTFH IN, Rs 178, Buy)
L&T Finance Holdings’ (LTFH) Q3FY18 performance reinforces our confidence in management’s sharpened execution focus, reflected in rapid strides in new business strategy wherein: a) growth is steered by focused business - ~26% YoY (de-focused business down 45% YoY); b) focus on expense & productivity management (C/I ratio down to ~23%); and c) fee income is robust (up >90%) leveraging cross-sell opportunities (albeit bit softer this quarter, despite higher sell downs), resulting in RoE of 15.9% (rural 27%, housing 31.7%, wholesale 10.1%).
Furthermore, LTFH is maintaining its strategy of utilising windfall gains (goodwill amortisation due to merger) to strengthen balance sheet via voluntary and accelerated provisioning. Despite this, LTFH reported Q3FY18 PAT (consolidated, pre-preferential dividend) of Rs 3.8bn (up >40% YoY). We believe with catalysts in place — strategic roadmap, targeted milestones and committed top brass, LTFH is set to generate ~20% RoE by FY20E (~10% in FY16), which could trigger further rerating. Maintain ‘BUY’.
HDFC (HDFC IN, Rs 1,968, Hold)
HDFC’s Q3FY18 PAT of INR56.7bn was largely aided by net investment gain of Rs 36.7bn (Rs 52.5bn from stake sale in HDFC Life, of which Rs 15.75bn was used to make contingency provisions). NII growth remained soft at ~14% YoY, which coupled with modest net fee income (Rs 400mn, indicating rising competitive intensity) led to sub-10% revenue momentum. However, there were signs of pickup in growth—overall loans grew >19% YoY (~15% average run rate in past eight quarters) led by non-individual (up >20% YoY) and individual (up 18.6% YoY benefitting from affordable housing) segments. GNPLs were steady at 1.15% (1.14% in Q2FY18).
Despite steady operational performance, valuation at 2.6x FY19E P/BV (core mortgage after building in capital raise) appears fair for core operating profit growth of ~16% and RoE of 16% in FY20E. Hence, maintain ‘HOLD’.
Given its market leadership position, HDFC is envisaged to be a key beneficiary of government’s/regulator’s thrust on the housing sector, lending growth visibility (signs visible this quarter onwards). Best-in-class cost ratios and adequate provisioning buffer will ensure steady operational performance. Value discovery via listing of HDFC Mutual Fund will be a positive trigger. As we build in the capital raising and roll to FY20E earnings, we revise our SoTP-based target price to Rs 2,130 assigning 3.5x FY20E P/ABV to its mortgage business (Rs 1,777 earlier). We. therefore, maintain ‘HOLD/SP’.
HDFC Securities recomendations:
Shriram Transport Finance Co (3QFY18): Maintain BUY
(TP Rs 1,669, CMP Rs 1,432, MCap Rs 325bn)
SHTF continued to exhibit its dominance in the used CV space with yet another solid show. Disbursements hit an all-time high (+65/8% YoY/QoQ) driven by higher demand for new CVs. Lower provisioning (down 4% YoY) and better asset quality performance (GNPA down 8bps QoQ) led to a net earnings growth of 43% YoY. Sticky NIMs, (7.5%) despite the fall in yields was a positive surprise We believe SHTF’s widening presence and unparalleled acumen in the used CV market gives it a competitive edge. An uptick in the capex cycle will not only propel growth but also help in asset quality healing.
Mid-teen growth, moderation in provisioning and reduction in CoF will crystallize into a RoAA improvement of 36bps over FY18-20E. With our conservative NIM and provisioning estimates, an earnings beat is likely. Maintain BUY with a TP of Rs 1,669 (2.75x Dec-19E ABV of Rs 607).
Motilal Oswal recomendations
A play on potential margin expansion: 3QFY18 revenue grew 3.8% QoQ to $ 122.5 mn, in line with our estimate of $122 mn. YoY growth was 12.3%v/s in 2Q. While Digital segment grew 9.2% QoQ, excluding the Parx acquisition, organic growth was 4% QoQ, tepid by its standards. Accelerite was soft too, with revenue down 17% QoQ. Sustained revenue growth needs replacement of end-of-life products with new solutions – which, however, is some time away, in our view.
PAT increased 11% QoQ to Rs917m, above our estimate of Rs 862m, led by operating beat and a lower effective tax rate of 22% (estimate of 25%).
Valuation and view: Our positive thesis on PSYS was based on the bottoming out of margins in FY17, and flat 9MFY18 margins YoY have been on expected lines. We believe that further upside in PSYS will need margins to expand from current levels. We see a three-pronged possibility for the same:  Reversal of IBM IoT margins to positive next fiscal,  Continued improvement in margins in Digital and  Continued focus on non-linear characteristics of incremental revenues. We estimate 130bp improvement over FY19 and FY20 to 17.2%. Our price target of RS900 discounts forward earnings by 15x, with the target multiple embedding its focus on high-quality revenue growth and levers to margin expansion. Maintain Buy.
Realisation miss due to weaker pricing in focus markets: Revenue grew 12% YoY (-2% QoQ) to Rs 5.1 bn (est. of Rs 5.9b), as volumes rose 9% YoY to 1.37mt (est. of 1.44 mt). However, volumes were lower than estimated, as, unlike in 2QFY18, it sold less volume in distant markets. Realizations stood at Rs3,737/ton (-6% QoQ; est. of flat QoQ) due to weaker pricing and also a reduction in FOR sales on a sequential basis.
Valuation view: The proposed acquisition of JPA’s assets would help ORCMNT to raise capacity by 38% at reasonable valuation and to reduce lead time significantly. While the move would be dilutive to earnings and return ratios over the near term, it will help ORCMNT become a pan-India player by diversifying into newer markets of central/east India. We like the quality of assets, and thus, believe that combined valuation of USD85/t (i.e. Orient’s current + proposed asset valuations) is attractive.
The stock trades at EV of 10.8x/7.8x FY19E/20E EBITDA and ~USD77 per ton on standalone operations. We value ORCMNT at EV/ton of USD86 on FY20E, at a ~30% discount to replacement cost, and accordingly assign a TP of Rs179. Buy.
Ashoka Buildcon (CMP: Rs250 TP: Rs 275 (+10%) Buy
We expect revenue growth of 19% YoY, led by a pick-up in the execution of the Eastern Peripheral Expressway project, which had faced hurdles in 2QFY18.
We expect operating margin to improve 70bp to12.5% and operating profit to improve 26% YoY to Rs 779 mn. Net profit is expected to remain flat, given an increase in interest and depreciation charges. Maintain Buy.
Key issues to watch
- Execution pick-up in the Eastern Peripheral Expressway, given work obstruction witnessed in 2QFY18.
- Pick-up in supplies from vendors post contract renegotiation on account of GST implementation.
CMP: Rs181 TP: Rs 210 (+16%) Buy
For FY18, BHE plans to pursue business opportunities in solar energy, homeland security, smart cities, smart cards and telecom. For FY18, BHE’s growth would be driven by radar/missile systems, communication and network centric systems, tank electronics, gun upgrades, electro-optic systems, and electronic warfare systems. BHE has planned capacity enhancement and creation of new test facilities for the defence business.
We expect BHE to register revenue growth of 14% YoY, supported by execution of Akash missile system, IACCS, and ship-borne EW systems. We expect gross margin to decline 560bp YoY to 45%, led by adverse product mix and lower contribution from the service segment, which is a higher-margin business. We expect EBIDTA margin of 16.1% v/s 23.1% in 3QFY17 on account of weak product mix. EBITDA could decline 21% YoY to Rs3.8b. PAT is expected at Rs3.0b (-18.5% YoY). Maintain Buy.
Key issues to watch
- Revenue growth: Key orders (Akash missile, intake of Rs67b in FY11-12) are currently under execution for Army and Air Force.
- Operating at 60% capacity utilization; possibility of strong operating leverage.
Cholamandalam Inv & Fin
CMP: Rs1,304 TP: Rs1,500 (+15%) Buy
With strong growth in the VF segment, coupled with gradual improvement in LAP, we expect AUM growth to pick up to 16% in 3QFY18 compared to 14.4% in the prior quarter. Spreads are expected to be stable sequentially, but up 40bp on a YoY basis, largely due to lower cost of funds. As a result, NII growth is expected to be strong at 24% YoY. Calculated cost-to-income ratio should decline 50bp to 41.9%.
We expect C/I ratio to remain at 40-41% levels for the next few quarters. We believe GNPLs have topped out and should decline going forward, as the company has started invoking SARFAESI. We expect provisions of Rs1b v/s Rs0.8b in 2QFY18 and Rs 1b in 3QFY17. Net profit is likely to grow 36% YoY to Rs 2.21b. The stock trades at 3.4x FY19E and 2.8x FY20E BV. Maintain Buy.
Key issues to watch for
- Business growth trends and management commentary on the same.
- Impact of GST on business going forward.
- Trend in opex, given management’s intent to reduce expense ratio to 2.5% by FY20.